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Abstract: Snake venoms are complex mixtures of toxic proteins encoded by various gene families
that function synergistically to incapacitate prey. A huge repertoire of snake venom genes and
proteins have been reported, and alternative splicing is suggested to be involved in the production
of divergent gene transcripts. However, a genome-wide survey of the transcript repertoire and
the extent of alternative splicing still remains to be determined. In this study, the comprehensive
analysis of transcriptomes in the venom gland was achieved by using PacBio sequencing. Extensive
alternative splicing was observed in three venom protein gene families, metalloproteinase (MP),
serine protease (SP), and vascular endothelial growth factors (VEGF). Eleven MP and SP genes and a
VEGF gene are expressed as a total of 81, 61, and 8 transcript variants, respectively. In the MP gene
family, individual genes are transcribed into different classes of MPs by alternative splicing. We also
observed trans-splicing among the clustered SP genes. No other venom genes as well as non-venom
counterpart genes exhibited alternative splicing. Our results thus indicate a potential contribution of
mRNA alternative and trans-splicing in the production of highly variable transcripts of venom genes
in the habu snake.
Keywords: venom genes and proteins; metalloproteinase; serine protease; vascular endothelial
growth factor; transcriptome variants
Key Contribution: Alternative mRNA splicing in the production of highly variable transcripts of
snake venom genes.
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1. Introduction
Many snakes have evolved the ability to produce venom, which is a complex mixture of toxic
proteins. The toxic proteins contained in the venom are encoded by genes classified into more
than ten gene families [1–3]. Protein components of venom are highly variable from species to
species. Even within a species, these may vary from population to population and from individual to
individual under different physiological and/or environmental conditions. This extensive diversity
makes a full characterization of their repertoire difficult. However, recent venomics studies, including
high-throughput transcriptomics (RNA-seq), have demonstrated a highly divergent profile of mRNAs
encoded by venom genes, and the involvement of alternative splicing is suggested to contribute to
transcriptome variety [4–6]. In the era of genome science, the extent of alternative splicing can be
examined on a genome-wide scale.
In a previous study, we constructed a draft genome sequence of the habu snake, Protobothrops
flavoviridis [7]. An approximately 1.4 Gbp genome assembly, HabAm1, was estimated to contain
25,134 protein-coding genes. A comprehensive annotation of habu genes with the aid of a large
transcriptome dataset from 18 different organs has identified a total of 60 venom genes, which are
categorized into 18 families [7]. These are metalloproteinase (MP), serine protease (SP), C-type
lectin-like proteins (CTLP), phospholipase A2 (PLA2), three-finger toxins (3FTX), aminopeptidases
(APaseN), cysteine-rich secretory proteins (CRISP), vespryns/SPla and ryanodine receptor domain
proteins (Vespryn), 5′-nucleotidases (5Nase), dipeptidyl peptidases (DDPase), hyaluronidases (Hyal),
nerve growth factors or neurotrophins (NGF), vascular endothelial growth factors (VEGF), L-amino
acid oxidases (LAAO), phosphodiesterases (PDE), phospholipases B (PLB), bradykinin-potentiating
peptides and C-type natriuretic peptides (BNP), and glutaminyl peptide cyclotransferases (GPCase).
The first four constitute major families of habu venom proteins [3], including 11 gene copies of svMP
(sv, snake venom) and svSP, 10 of svCTLP, and 9 of svPLA2. Multiple copies of these gene families
were likely formed by multiple rounds of duplications of each of the original venom gene copies [7].
In addition to the accelerated evolution, alternative splicing has been reported as a diversifying
mechanism in snake venom proteins such as acetylcholinesterases [8] and svSPs [9,10]. However,
alternative splicing in venom protein genes has not been genome widely tested. In the present study,
we have collected a large quantity of RNA-seq data obtained on a PacBio RSII platform, as well as
by Illumina next-generation sequencing (NGS), for the annotation of HabAm1 genes. We describe
details of transcripts of venom genes, carefully annotated by using Iso-Seq (isoform sequencing) long
reads that span entire transcript isoforms, from the 5′ end to the 3′ polyA-tail. We also addressed the
following questions: (1) How many venom genes exhibit alternative mRNA splicing? (2) how many
splice variants are produced? and (3) by what mechanisms?
2. Results
2.1. Alternative Splicing Occurs in Three of the 18 Families of Venom Genes
As indicated, our previous study demonstrated 18 families of 60 venom and 224 non-venom
counterpart genes [7]. In the previous study, we also obtained a total 97,405 reads of cDNA collected
from the venom gland using PacBio RSII (Iso-Seq) (a total read-length = 179,143,509 bp). We manually
annotated these full-length transcripts corresponding to the gene models previously constructed.
As a result, we observed alternative splicing exclusively in three families of venom genes: MPs, SPs,
and VEGFs (Figures 1–3). No other families of venom genes, including PLA2s, showed alternative
splicing (Figure 4). In other words, each of the transcripts of the remaining 15 venom gene families
showed one-to-one correspondence to appropriate venom gene models. svMP and svSP are two of
the four major components of habu venom. In contrast, svVEGF is a member of the group in which
a single-copy gene is transcribed into one corresponding mRNA. This indicates that (1) alternative
splicing contributes to the production of mRNA variants exclusively in venom genes, and (2) alternative
splicing occurs only in a few venom gene families, not commonly shared by all venom gene families.
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Figure 1. Cont.
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Figure 1. Schematic diagram of structures of metalloproteinase (MP) genes expressed in habu
venom glands. svMP03-VMP-III-like (A), svMP01-HV1 (B), svMP02-flavorase (C), svMP09-HR1b-related
(D), svMP05-HR1a-relate (E), svMP11-NaMP (F), svMP04-jerdonitin-like (G), svMP10-elegantin-like (H),
svMP07-HR2a-related (I), svMP08-flavoviridin (J), and svMP06-H2-protease (K) are shown with validated
transcript variants, verified as expressed in the venom gland. Initiation and stop-codons are marked
with “M” and slashes, respectively. Active sites are shown with red arrowheads located in exon 11.
The original transcripts predicted by the gene models are underlined. Both svMP08-v1 and v2 are
original transcripts, of which amino acid 275 are indicated by E(Glu) and K (Lys), respectively. Numbers
of transcript variants and the type of metalloproteinases are shown on the right.
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Figure 2. Schematic diagram of structures of serine protease (SP) genes expressed in habu venom
glands. svSP07 (A), svSP01-TLf1-flavoxobin (B), svSP02-TLf2 (C), svSP03-TLf3 (D), svSP04 (E), svSP05
(F), svSP08 (G), svSP09 (H), svSP06 (I), svSP10 (J), and svSP11 (K) are shown with validated transcript
variants, verified as expressed in the venom gland. Initiation and stop-codons are marked with “M”
and slashes, respectively. His, Asp, and Ser residues of the catalytic triad are indicated as “H”, “D”,
and “S”, respectively. In svSP02-TLf2, the His residue “H” of the catalytic triad is substituted by Arg
(R). Numbers of transcript variants are shown on the right. The original transcripts predicted by the
gene models are underlined.
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Figure 3. Schematic diagram of structure of vascular endothelial growth factor (VEGF) genes expressed
in habu venom glands. Initiation and stop-codons are marked with “M” and slashes, respectively.
Seven transcript variants, svVEGF-v1 to v8, were identified. Numbers of transcript variants are shown
on the right. The original transcript predicted by the gene models is underlined.
Figure 4. Schematic diagram of structure of phospholipase A2 (PLA2) genes expressed in habu
venom glands. svPLA2_01-Asp49PLA2 (A), svPLA2_02-PLX’/PL-Y/PLA-B (B), svPLA2_03-PLA-N
(C), svPLA2_04/05/06-BPI/BPII/BPIII (D), svPLA2_07-pgPL1b/PL2b (E), svPLA2_08-PfPLA6 (F), and
svPLA2_09-pgPLA2b (G) are shown with validated transcript variants expressed in the venom gland.
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Initiation and stop-codons are marked with “M” and slashes, respectively. Numbers of transcript
variants are shown on the right.
2.2. Alternative Splicing of 10 svMP Genes Produces 81 mRNA Variants
MPs are key toxins that cause venom-induced pathogenesis such as hemorrhage, fibrinolysis, and
apoptosis. According to their domain architecture, svMPs are classified into four groups (P-I to P-IV) [11]
(Figure 5A). P-I MPs possess only the metalloproteinase domains and are largely non-hemorrhagic.
P-II MPs contain MP domains and disintegrin domains. P-III MPs contain Cys-rich domains as well as
MP and disintegrin domains and exhibit great diversity in structure and function. P-IV MPs harbor
lectin-like domains linked by disulfide bonds to the P-III-like structures [11]. Eleven svMP genes
have been annotated from the habu gene model, HabAm1 (svMP01 to svMP11) (Figures 1 and 5B;
Supplementary Table S1).
In the present study, we obtained 1777 PacBio reads related to the svMPs, however only 1032
PacBio reads out of 1777 can be assigned on the svMP genes, svMP01 to svMP10. Residual 745 PacBio
reads for svMPs could not assigned on svMP genes probably due to their non-perfect match to the
known svMPs. This suggests that the additional new svMP genes exist in the habu genome. After
removing the short PacBio reads (total 839 reads), 193 full-length transcripts (PacBio reads) that include
both start Met codon and polyA signal were used for further analysis.
As shown in Figures 1 and 5B, the svMP genes consist of 13 to 17 exons. Six svMP genes,
svMP01-HV1, svMP02-flavorase, svMP03-VMP-III-like, svMP05-HR1a-related, svMP09-HR1b-related and
svMP11-NaMP-like consist of 17 exons. Four svMP genes, svMP04-jerdonitin-like, svMP07-HR2a-related,
svMP08-flavoridin, and svMP10-elegantin-like consist of 15 exons. Only svMP06-H2-protease consists of
13 exons. Exon 1 encodes a signal sequence, and exons 2 to 6 encode pre-prosequences. Exons 7 to 12
encode MP domains, including a catalytic zinc binding motif, HEXGHNLGXXHD encoded by exon 11 in
all svMP genes (Figure 5A). Furthermore, exons 13 and 14 encode the disintegrin domains of P-II and
P-III svMPs, and exons 15 and 16 encode the Cys-rich domain of P-III svMPs (Figure 5A). A molecular
phylogenetic tree constructed from nucleotide sequences of P. flavoviridis svMPs is shown in Figure 5B.
The gene structure with 17 exons, as seen in svMP11-NaMP-like, is suggested to be ancestral due to its
basal location in the phylogenetic tree (Figure 5B). svMP02-flavorase, svMP01-HV1, svMP03-VMP-III-like,
svMP05-HR1a-related, and svMP09-HR1b-related have diverged from this ancestor without any structural
changes to exons. On the other hand, exons 15 and 16 corresponding to the Cys-rich domain were deleted
in the four genes consisting of 15 exons: svMP04-jerdonitin-like, svMP10-elegantin-like, svMP07-HR2-related,
svMP08-flavoridin, and svMP06-H2-protease (Figures 1 and 5B).
In the case of svMP06-H2-protease, exons 13 and 14 corresponding to the disintegrin domain were
further deleted, resulting in 13 exons (Figure 5B). An important notion is that the last exon, exon 17 in
the original construct, is conserved in all of the “reduced” gene copies consisting of 13 or 15 exons.
These gene structures suggest that the ancestral svMP gene copy related to svMP11-NaMP consisting
of 17 exons duplicated into multiple copies, and some of the copies were then modified by two-round
deletions, the first one involving loss of exons 15 and 16, and the second one resulting in further loss of
exons 13 and 14, resulting in 11 svMP gene copies with different numbers of exons (Figure 5B).
All of the 81 full-length mRNAs expressed in the venom gland matched each of the
corresponding gene models. We identified multiple kinds of transcripts for each of the MP
genes except for svMP11-NaMP, which expressed only one type of the transcript (Figure 1F;
Supplementary Table S1). We hereafter call the transcript completely matching the corresponding
gene model as “original” represented by svMP03-v1 for svMP03-VMP-III-like supported by six
Iso-Seq reads (Figure 1A). Besides the original transcripts, we observed 2, 5, 6, 5, 18, 0, 5,
1, 12, 16, and 1 variant transcripts for the other MP genes. (Figure 1A–K). These variants
include transcripts, of which 3′ untranslated regions’ (3′UTR) length is the only thing that is
different due to having multiple polyA signals AATAAA, and which are able to translate the same
protein products. For example, they include svMP03-v1 and svMP03-v2 for svMP03-VMP-III-like,
svMP01-v1, svMP01-v2 and svMP01-v3 for svMP01-HV1, svMP02-v1, svMP02-v2 and svMP02-v3
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for svMP02-flavorase, and svMP09-v2 and svMP09-v3 for svMP09-HR1b. We also observed variable
positions of the stop-codon in svMP01-HV1-related, svMP02-flavorase-related, svMP09-HR1b-related,
svMP05-HR1a-related, svMP04-jerdonitin-like, svMP07-HR2a-related, svMP08-flavoridin, and
svMP06-H2-protease (Figure 1B–E,G,I–K). Most of these differences are associated with exon skipping
or intron retention followed by frame shifts. For example, three different transcript variants of
svMP09-HR1b show variable positions of the stop-codon, svMP09-v4 skipping exon 15 with a new
stop-codon in exon 16, svMP09-v6 retaining intron 13 with a new stop-codon in the newly fused exon
(exons 13 and 14), and svMP09-v5 retaining intron 14 with a new stop-codon in the newly fused exon
(exons 14 and 15) (Figure 1D), resulting in the variants corresponding to P-I and P-II MPs, respectively.
Figure 5. Schematic structures (A) and phylogenetic tree (B) of metalloproteinase genes expressed in
habu venom glands. (A) The gene structure is shown with 17 exons. A Zn binding site is also shown in
exon 11. Different domains in the three types of MP protein products (P-I, P-II, and P-III/P-IV) are shown
as boxes. The active site is also shown by asterisk as “Zn2+ binding” motif, HEXGHNLGXXHD. P-IV
contains lectin-like domain linked by disulfide bonds to the P-III structures. (B) Molecular phylogeny
of 11 MP genes. Three non-venom MPs found in the habu genome, nvMP08, nvMP09, and nvMP11
were used as outgroups for rooting the tree. Bootstrap probabilities of 1000 replications are shown at
each node. Deduced timings of gain and loss of exons are shown by blue arrows. Exon structures and
numbers of transcript variants are also shown on the right.
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The most extensive variations were noted in svMP05-HR1a-related, showing the original transcript
svMP05-v1 supported by 10 Iso-Seq reads and 17 variant transcripts, svMP05-v2 to svMP05-v18,
supported by 1 to 4 Iso-Seq reads, respectively (Figure 1E). Unlike other svMP genes, extra sub-exons
(1b, 1c, 1d, and 1e) were observed between the original exon 1 and exon 2 in some transcript variants
such as svMP05-v2, The original transcript and 12 variants contained only the original exon 1a, while
another six transcript variants exhibited more complicated combinations of exon usage characterized
by loss or fusion of certain exons (svMP05-v2, svMP05-v3, svMP05-v4, svMP05-v5, and svMP05-v6 in
Figure 1E). Five of the six variants also showed different positions of the start-codon due to different
exon usage (svMP05-v3, svMP05-v4, svMP05-v5, and svMP05-v6 in Figure 1E). Six exons, exon 7 to
exon 12 encoding the MP domain, including the catalytic Zn finger motif (in exon 11), are conserved in
all of the observed transcripts, suggesting that the six exons are essential for enzyme function (Figures
1 and 5A). It is notable that the original transcript of svMP05-HR1a-like encodes P-III MP, while two
other types of svMPs are also transcribed from the same gene by alternative splicing. Six transcripts
encode P-I type, in which a stop-codon was introduced after exon 12 due to the retention of intron
12 (transcripts svMP05-v12, svMP05-v14, svMP05-v15, and svMP05-v16). Another two transcripts
encode P-II-type in which a stop-codon was introduced after exon 14 due to the retention of intron 14
(transcript: svMP05-v9) or shortening of exon 14 (transcript: svMP05-v10).
svMP04-jerdonitin-like, svMP10-elegantin-like, svMP07-HR2a-related, and svMP08-flavoridin are likely
to comprise another group of svMP genes of which the original construct is composed of 15 exons
encoding P-II MPs (Figure 1G–J). As observed above for the genes that originally consisted of 17 exons,
variable transcripts were produced by exon skipping and intron retention (Figure 1G–J). The most
extensive variation in this group was observed in svMP08-flavoridin, which is expressed as 15 variant
transcripts and two original ones (Figure 1J). Both svMP08-v1 and svMP08-v2 were original transcripts,
of which amino acid 275 is replaced by Glu or Lys. Another transcript, svMP08-v3, carrying fused exons
14 and 15 by retaining intron 14 was a P-II type with a disintegrin domain. However, three variant
transcripts, svMP08-v4 carrying fused exons 13 and 14 by retaining intron 13, svMP08-v5 eliminating
exon 14 and svMP08-v6 eliminating exons 14 and 15, were P-I type. Extensive variations were also
observed in svMP07-HR2a-related, expressed as 12 variant transcripts, svMP07-v2 to v13 as well as the
original transcript (Figure 1I). Although the first five exons, exon 1 to 5, are shared by all of the nine
transcripts, intron retentions are involved in the variant transcripts, svMP07-v3 carrying fused exons 11
and 12 by retaining intron 11, svMP07-v2 carrying short exon 14, c110395_f1p2_2139 carrying extended
exon 8, svMP07-v5 carrying extended exon 11 by partial retain of intron 11, svMP07-v13 retaining
intron 6, svMP07-v8 retaining intron 7, svMP07-v9 retaining introns 7 and 11, and svMP07-v11 and
svMP07-v12 partially retaining intron 7 (Figure 1I). New stop-codons are gained in the retained intron
11 in two transcripts encoding P-I MPs: svMP07-v3 and svMP07-v5, which can be produce the same
protein. Lastly, svMP06-H2-protease, consisting of 13 exons, is transcribed into a variant, svMP06-v2
gaining a stop-codon in the retained intron 11 as well as the original construct (Figure 1J).
To confirm the expression level of each transcript variant for svMPs, we analyzed the
prevalence and relative abundance of the splice variants in venom gland by HISAT (hierarchical
indexing for spliced alignment of transcripts), StringTie, and Ballgown with Illumina RNA-Seq
data (Figure 6). The relative abundance of the splice variants for other svMPs were obtained
except for svMP04 and svMP09. They could not be obtained due to their gene structures locating
across the multi-scaffolds, that is, svMP04 is located on habu1_scaffold415864, habu1_scaffold191139,
and habu1_scaffold403873, and svMP09 is located on habu1_scaffold3258, habu1_scaffold399953,
habu1_scaffold411246, habu1_scaffold399953, and habu1_scaffold400013. These data suggest the
existence of the several splice variants of svMPs in venom gland. For example, in the case for
svMP05-HR1a gene, distinct expression of transcript variants for svMP05-v1 to v18 was detected by
Illumina RNA-seq except for svMP05-v6, svMP05-v7, svMP05-v8, svMP05-v10, svMP05-v12, and
svMP05-v16. These differences of expression profiles between Illumina RNA-seq and PacBio reads may
be individual specificities. Interestingly, svMP05-v15 corresponding to P-I type MP showed higher
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expression (Fragments Per Kilobase of exon per Million mapped fragments (FPKM) 2769.20) compare
with svMP05-v1 corresponding to P-III type MP, HR1a (FPKM 247.38) (Figure 6D).
Figure 6. Cont.
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Figure 6. Structure and expression levels of distinct transvariant forms of svMPs genes in habu
venom glands. (A) scMP03_VMP-III like, (B) svMP01_HV1, (C) svMP02_flavorase, (D) svMP05_HR1a,
(E) svMP11_NaMP, (F) svMP10_elegantin-like, (G) svMP07_HR2a, (H) svMP08_flavoviridin, and (I)
svMP06_H2 protease. Expression levels are shown on the right with FPKM values.
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As described, svMPs are classified into four different groups (P-I to P-IV). Different types of MP
proteins may be produced from single MP genes such as svMP09-HR1b-related and svMP05-HR1a-related
not only by proteolytic processing but also alternatively splicing, resulting in a variety of svMPs and
disintegrin peptides.
2.3. Alternative Splicing of svSP Genes Produces mRNA Variants with Different Lengths of 3′UTR or Inactive
Short Forms Lacking C-Terminal Region
SPs are another major group of protein components of snake venom. We identified 11 habu svSP
genes (svSP01 to svSP11) from the gene model of HabAm1 (Figure 2; Supplementary Table S2) [7].
svSP01 is known as flavoxobin, TLf1, or habutobin, which is the most abundantly expressed svSP in the
venom gland [12–14]. It encodes a thrombin-like enzyme of 242 amino acids that specifically releases
fibrinopeptide A from fibrinogen [12]. svSP02 corresponds to another major svSP transcript encoding
a basic thrombin-like enzyme, TLf2. Comparative analyses of nucleotide sequences of P. flavoviridis
svSPs with orthologues previously reported from other snake species [15] enabled us to assign svSP03,
svSP04, svSP05, and svSP09 genes to basic thrombin-like enzyme TLf3, a new SP homologous to
stejnefibrase-1, flavorase, and an α-fibrinogenase, respectively.
All svSP genes are composed of six exons, except svSP06 which has two new exons (Figures 2
and 7). A molecular phylogenetic tree of the 11 svSP genes suggests that svSP08 is likely to be the
earliest-diverged variant from the ancestral state, followed by multiple stages of duplications and
divergence (Figure 2). As shown in Figures 2 and 7, in all 11 svSP genes, irrespective of the number of
exons, the first exons correspond to 5′ UTRs. All of these svSPs share the same exon–intron junctions as
the coding regions of mammalian kallikrein (KLK) genes [16]. Together with the similarity of enzymatic
activities and the conservation of primary and tertiary structures of SPs, it has been thought that the
ancestral copy of all svSPs is a kallikrein-like SP rather than other types of SPs such as elastase. This
further suggests that svSP06 gained two new exons, exons 7 and 8, resulting in extension of the 3′ UTR
(Figure 2I).
Figure 7. Molecular phylogeny of serine protease genes expressed in habu venom glands. A non-venom
SP found in the habu genome, nvSP05-kallikrein, was used as an outgroup for rooting the tree. Bootstrap
probabilities of 1000 replications are shown at each node. Deduced timing of gain of exons is shown by
a blue arrow.
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A great variety of transcripts of svSP genes was observed, indicating extensive alternative splicing
of svSP genes as seen in svMP genes (Figures 2 and 7). svSP08, svSP09, svSP10 and svSP11 express
three transcript variants each, including the “original” transcript deduced from the gene model.
svSP02-TLf2, svSP03-TLf3, and svSP05 are transcribed into six variants. svSP01-TLf1-flavoxobin and
svSP06 are transcribed into seven variants. svSP04 is transcribed into eight variants. svSP07 is
transcribed into nine variants. As seen in MP genes, we noticed several mechanisms to produce
transcript variants. For example, among the eight transcripts expressed from svSP04, skipping
of exon 2 was observed in five transcript variants, resulting in gain of a new start-codon in exon
3 of the original construct (svSP07-v3, svSP07-v4, svSP07-v5, svSP07-v6, svSP07-v7) (Figure 2E).
Furthermore, variant transcripts completely or partially retaining intron 4 result in gaining a new
stop-codon in the original intron 4 (svSP07-v5, svSP07-v6, svSP07-v7, and svSP07-v8). In addition,
unlike svMP genes, the svSP transcript variants show variable lengths in the 3′-region of exon 6
due to multiple polyA signals (Figure 2A–D,G,H,K). Furthermore, we observed variant transcripts
derived from trans-splicing involving exons in two to three tandemly arranged neighboring genes
(Figure 8). For example, c252215_f1p2_2614 was transcribed from exons 1–5 of svSP03-TLf3 and exon 6
of svSP01-TLf1-flavoxobin which is located downstream of svSP03-TLf3 (Figure 8A). c258868_f2p6_2221
was transcribed from exons 1–3 of svSP01-TLf1-flavoxobin and exons 4–6 of svSP09 which is located
downstream of svSP01-TLf1-flavoxobin (Figure 8A). c50972_f1p2_1888 was transcribed from exons 1–3
of svSP04, exons 4 and 5 of svSP05 and exon 6 of svSP08. c552059_f9p9_1588 was transcribed from
exons 1–3 of svSP04 and exons 4 and 5 of svSP05 (Figure 8B). c8598_f5p23_1588 was transcribed from
exons 1 and 2 of svSP04 and exons 3–6 of svSP05 s (Figure 8B). c39314_f4p1_3574 was transcribed from
exons 1–3 of svSP04 and exons 4–6 of svSP08 genes (Figure 8B). All of these trans-spliced products
were supported by multiple Iso-Seq reads. Therefore, intrinsic trans-splicing serves as a previously
unknown mechanism to enhance the diversity of final protein products of svSP genes.
Figure 8. Chimeric transcripts generated by trans-splicing of clustered genes. Trans-spliced transcripts
were identified from two regions of SP gene clusters, habu1_scaffold 7597: 85001...158000 (A) and
habu1_scaffold6789: 133001...203400 (B). All of these trans-spliced transcripts were supported by
multiple Iso-Seq reads.
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2.4. VEGF Gains Its C-Terminal Modification by Alternative Splicing
VEGFs are key regulators of vascular development during embryogenesis (vasculogenesis),
blood-vessel formation (angiogenesis), skeletal growth, and reproductive functions [17]. We identified
three VEGF genes from the gene model of HabAm1. One is the toxic copy, svVEGF01
(habu1_s565_g02679) encoding svVEGF-F, while the other two are non-toxic copies, nvVEGF01
(nv: non-venom; habu1_s6836_g17529) and nvVEGF02 (habu1_s9381_g19343) encoding VEGF-A and
VEGF-C, respectively. In the current analysis we identified eight transcript variants expressed from
svVEGF01 (Figure 3). The “original” transcript, svVEGF-v1 was the major transcript encoding the
full-length length amino acid sequence exactly matching the one previously reported [18]. In contrast,
all transcript variants carry variably shortened coding sequences. svVEGF-v2 gained a stop-codon in
the retained intron 5. In spite of the difference in structures of exons 5 and 6, svVEGF-v3, svVEGF-v4,
svVEGF-v5, and svVEGF-v6 commonly gained a stop-codon in the retained intron 3, resulting in an
identical protein product. svVEGF-v7 gained a stop-codon in the retained intron 1, resulting in a highly
truncated protein. svVEGF-v8 gained a new stop-codon in exon 3 due to skipping of exon 2, resulting
in a very short protein.
2.5. PLA2s Show No Alternative Splicing
PLA2 (EC 3.1.1.4) catalyzes the hydrolysis of 2-acyl ester bonds of 3-sn-phosphoglycerides in
the presence of Ca2+, to liberate 3-sn-lysophosphoglycerides and fatty acids. Habu snake genome
contains nine types of group II venom PLA2 genes (svPLA201 to svPLA209) (Figure 4) [7], including a
hemolytic [Asp49]PLA2 (svPLA201), edema-inducing basic [Asp49]PLA2 including PLX’, PL-Y and
PL-B (svPLA202), a weak neurotoxin PLA-N (svPLA203), and [Lys49]PLA2 myotoxins (svPLA204 to
svPLA206 corresponding to BPI, BPII, and BPIII, respectively), were expressed in the venom gland with
high number of transcripts (16–3206) compared with three genes, svMP, svSPs, and svVEGF (Figure 4).
From the structure of each transcript, svPLA2s have no alternative splicing although these PLA2 genes
consist of four exons (Figure 4).
Total number of transcripts for PLA2s was estimated to be 9654, ten percent of 97,405 Iso-Seq reads
in venom gland. Compared with PLA2s, total number of reads for svMP, svSPs, and svVEGF were
low with 1777, 476, and 20, respectively. On the other hand, FPKM values of svPLA2s, svMPs, svSPs,
and svVEGF in venom glands from two individuals (VG1/VG2) were estimated to be 3590.15/13728.43,
6140.1/1138.4, 149.2/630.8, and 90.4/116.9, respectively. These results suggest that the expression levels
of svPLA2s, svMPs, svSPs, and svVEGF estimated by two different methods, PacBio Iso-Seq reads
and Illumina RNA-seq, were almost parallel. However, the number of full-length transcripts (Iso-Seq
reads) for svMPs were very low, more than the difference of expression levels probably due to their
short reads and the existence of unidentified svMP genes. Furthermore, PLA2s are much easier to
identify (only four exons, <450 bp usually for the coding sequence) so the models may be much better
for them. With svMPs having 15–17 exons (>1400 for Type 2 and >1800 for Type 3), there is a lot more
possibility of errors in annotation.
3. Discussion
Previous studies have suggested the occurrence of alternative splicing of venomic SP genes in
Vipera lebetina and Bitis gabonica rhinoceros [9,10]. Recent high-throughput transcriptomics (RNA-seq)
demonstrated a highly divergent profile of mRNA species encoded by venom genes, and the
involvement of alternative splicing is suggested to contribute to transcriptome variation [4–6].
Genome-wide transcriptome analyses, including alternative-splicing variants of venom genes, have
not been previously reported. By genome-based comprehensive analysis of the full-length transcript
information provided by Iso-Seq reads of the venom gland in P. flavoviridis, we showed that only
three of the 18 families, namely svMP, svSP, and svVEGF, produce highly diverse transcript variants
by alternative-splicing in venom glands. Thus, the diversity of venom transcripts in P. flavoviridis is
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provided by two distinct mechanisms; namely, alternative splicing, as we reported in the current study,
and the increment of copy number followed by accelerated evolution, as we reported earlier [7].
The present study disclosed “double-decker” mechanisms; namely, extensive gene duplication
followed by the rearrangements of exon/intron structures. For examples, in the case of the 24 copies
of svMP genes, five copies preserved the original arrangement consisting of 17 exons, whereas four
copies are the “deleted” construct consisting of 15 exons, of which the terminal one is “further
deleted” carrying only 13 exons. The most extensive variation by alternative splicing was noticed
in svMPs; that is, transcript variants involving exon skipping or intron retention (fused exons)
incorporated a new stop-codon, resulting in the production of diverse variants corresponding to
different types of MPs. For example, from the genes encoding P-III-type MPs, HR1a, and HR1b,
all three types of variants were produced, P-I, P-II, and P-III. While from the P-II-type MP genes
such as svMP04-jerdonitin-like, svMP07-HR2a-related, and svMP08-flavoridin, two types variants were
produced, P-I and P-II. These transcript variants for each MP were confirmed by HISAT, StringTie,
and Ballgown with Illumina RNA-Seq data (Figure 6). The diversification mechanism by alternative
splicing may be advantageous for svMPs because they are mosaic proteins belonging to a disintegrin
and metalloprotease (ADAM) family, which contains the disintegrin and Cys-rich domains encoded by
separate exons, in addition to MP and pre-prosequence domains (Figure 5A).
In the case of the 11 copies of svSP genes, 10 copies retained the original architecture consisting
of six exons, whereas one copy gained two new exons, resulting in eight exons. Many of these
rearrangements involve gain and loss of start- and stop-codons. We identified transcript variants for all
of the 11 svSP genes carrying intron retentions as well as exon skipping, resulting in gains of premature
stop-codons or of secondary start-codons. Some transcript variants such as c768983_f1p7_7228 of
svSP01-TLf1-flavoxobin and c735101_f3p4_5942 of svSP02-TLf2 are very small and naturally devoid of
catalytic activity as proteinases due to lack of the catalytic residue, Ser195. Our unpublished data show
that TLf2 enhances the myonecrotic activity of [Lys49]PLA2, although TLf2 was hydrolytically inactive
due to replacement of its catalytic residue His57 with Arg (Ogawa et al., in preparation). This indicates
the possible functions of svSP fragmentary products derived from short-transcript variants because
TLf2 exhibits a unique activity independent of its protease activity.
In addition to the two major protein components in the venom MP and SP, alternative splicing also
serves to enhance the diversity in transcripts expressed from svVEGF (Figure 3). Transcript variants
of svVEGF carry variable stop-codon positions, such as retained intron 1, exon 3, retained intron 3,
and retained intron 5 and exon 6 (original). VEGFs in snake venoms are known to show highly strict
specificities of receptor-binding compared to mammalian VEGFs. For example, vammin and VR-1,
isolated from the venoms of Vipera ammodytes and Daboia russelii, respectively, bind only kinase insert
domain receptor (KDR) with high affinity but not to other VEGF receptors [19]. It is known that the
C-terminal regions of VEGFs are one of the determinants for receptor specificities [20,21]. Yamazaki et
al. [18] has also reported that svVEGF of P. flavoviridis preferentially binds to Flt-1 rather than to KDR,
unlike vammin and VR-1 [22]. Thus, transcript variants of svVEGFs with variable C-terminal regions
are likely to show differences in receptor specificities, rendering additional diversity in physiological
functions of the venom.
Besides the normal cis-spliced transcripts discussed above, we also observed trans-spliced
transcript variants of svSPs expressed from genes tandemly clustered so that the pre-mRNA spanning
multiple genes is able to be expressed (Figure 8). This may serve as yet another mechanism, which
is previously unknown, to enhance the diversity of venom protein products. In the current study,
we reported trans-splicing involving two regions of clustered genes, namely svSP03-svSP01-svSP09
and svSP04-svSP05-svSP08. In our previous study, however, we identified more cases of gene clusters
of MPs, SPs, and CTLPs in the habu genome. Therefore, it is highly likely that trans-splicing also
contributes to the expression of other neighboring genes located in the gene cluster, which needs to be
elucidated in future study.
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Because recent transcriptomic and proteomic analyses of snake venoms have revealed that the
venom components often show variations within as well as between species, it is considered that
diversification of these venomous proteins at the transcriptional level is advantageous for physiological
and environmental changes, including prey species [23–27]. These venom variations may be correlated
with geographic location, diverse environments, sexual dimorphism, and feeding behaviors. In the
current study, we revealed multilayered mechanisms that enhance the diversity of venom protein
products, namely, alternative splicing, and trans-splicing. These are likely to serve as intrinsic
mechanisms to render physiological and adaptive changes to the protein components of snake venoms.
4. Conclusions
In the present study, we found that alternative splicing was observed in three venom protein gene
families, MP, SP, and VEGF, that is, a total of 81, 61, and 8 transcript variants, respectively. Especially,
individual genes of MPs are transcribed into different classes of MPs by alternative splicing. We also
observed trans-splicing among the clustered SP genes. No other venom genes such as PLA2s exhibited
alternative splicing. Thus, our results indicate a significant contribution of mRNA alternative and
trans-splicing in the production of highly variable transcripts of venom genes in the habu snake.
5. Materials and Methods
5.1. Biological Materials
P. flavoviridis individuals were collected from Amami-Oshima Island, Kagoshima, Japan in 2011.
One female individual was used for RNA extraction from venom gland. Crude venom was collected
from adult P. flavoviridis from Amami-Oshima, Japan, and lyophilized. It was stored at −30 ◦C until use.
5.2. Transcriptome Analyses by PacBio Reads
Transcriptome analyses by PacBio reads were conducted as described in the previous our work [7].
Briefly, cDNA libraries from the venom gland for PacBio sequencing were prepared by using the
manufacturer’s protocol with a SMARTer Pico PCR cDNA Synthesis Kit (TAKARA Clontech) and
SMRTbell Template Preparation Kit 1.0 (PacBio). Longer cDNAs were enriched with a SageELF system
(Sage Science, Inc.). Sequencing was performed on a PacBio RS II, yielding a total of 179,143,509 bps of
2300 bp average read length. N50 of PacBio reads was 5000 and not required for further assembly.
Most of these reads are long enough to be full-length transcripts and directly annotated with BLASTX
against UniProt. PacBio reads are publicly available from DDBJ under accession no. DRA006601.
5.3. Transcriptome Analyses by Illumina
For transcriptome analyses by Illumina RNA-Seq, two individual venom glands (VG1 and VG2)
were used. Total RNA was extracted by using a standard TRIzol protocol procedure (Thermo Fisher
Scientific), and cDNA libraries were prepared using an NEBNext® Ultra™ Directional RNA Library
Prep Kit for Illumina (New England Biolabs). RNA quality was checked with an Agilent Technologies
2100 Bioanalyzer using an Agilent RNA 6000 Nano Kit. Sequencing was performed using an Illumina
Hiseq2500. The sequencing quality was checked by FastQC [28], and low complexity sequences were
removed by PRINSEQ [29]. The raw Illumina reads were quality filtered (Q20) and trimmed out
5–10 bp on both ends of the reads to remove bias and low-quality bases by using Trimmomatic [30].
De novo assembly of whole RNA sequence reads was performed using a de Bruijn graph-based
program, Trinity [31]. Assembled transcripts were annotated with BLASTX against UniProt. Illumina
reads are publicly available from DDBJ under accession no. DRA006600.
5.4. Mapping of Transcriptome Data on Genome Sequence and Detection of Transcript Variants
All PacBio Iso-Seq transcript reads were mapped against the genome assembly, HabAm1 using
BLAT [32] and PASA [33]. HabuAm1, the genome sequence data of P. flavoviridis previously reported [7],
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can be accessed in BioSamples SAMD00115727 (DRX006596-DRA006599). Accession numbers for
scaffolds are BFFQ01000001–BFFQ01084502 (84,502 entries).
PacBio Iso-Seq transcript data encoding venom proteins was checked and corrected via a habu
genome browser (Supplementary Figure S1). PacBio Iso-Seq transcript data for venom proteins was
also analyzed by blast search on habu1_venom pac bio_prot and habu1_venom_pac_bio_nucl database
of the habu genome browser using amino acid sequence and nucleotide sequence of each transcript
variant as query sequence. Finally, we confirmed the data by multiple alignments of transcripts against
each venom gene with ClustalW [34] and manual curation by comparing with genome sequence to
remove the sequencing errors and/or allelic variation. Short Iso-Seq reads without a start Met codon
and/or polyA signal were also omitted from data. Then, the number of validated transcript variants
were counted.
5.5. Bioinfomatic analysis
A genome browser was prepared using the assembled genome sequences using the
JavaScript-based Genome Browser (JBrowse) 1.11.6 [35]. The assembled sequence and gene models
can be found at http://marinegenomics.oist.jp/habu/.
Alignment of amino acid and nucleotide sequences of each protein family was first performed
using ClustalW online at http://clustalw.ddbj.nig.ac.jp. Then the alignment of nucleotide sequences
was made based upon the amino acid sequence alignment. We carefully and repeatedly confirmed the
correspondence between nucleotide sequences of the genome and mRNAs and amino acid sequences
of the predicted proteins.
Phylogenetic trees were constructed by the maximum-likelihood method using IQ-TREE (http:
//www.iqtree.org) [36], based on aligned nucleotide sequences. Numbers on branches are bootstrap
values with 1000 × resampling. The optimal evolutionary model for each phylogenetic tree was
selected using ModelFinder [37] implemented in IQ-TREE.
The expression level of transcript variants in venom gland was analyzed by Pertea’s protocols
using open source software tools [38], HISAT (hierarchical indexing for spliced alignment of transcripts.
Ver. 2.1.0) [39], StringTie (Ver. 1.3.4d) [40], and Ballgown (Ver. 2.16.0) [41] with Illumina RNA-Seq data.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6651/11/10/581/s1,
Figure S1: Habu genome browser, Table S1: Metalloproteinase (MP) genes and representative transcripts expressed
in the habu venom gland, Table S2: Serine protease (SP) genes and representative transcripts expressed in the
habu venom gland.
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